Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
Summary
Third Opinion Trial Synopsis:
This study is checking if a new medicine called isatuximab is safe and works well when given with normal medicine for people who just found out they have a cancer called multiple myeloma.
This study is checking if a new medicine called isatuximab is safe and works well when given with normal medicine for people who just found out they have a cancer called multiple myeloma.
*Third Opinion AI Generated Synopsis
Trial Summary
This research is testing whether the investigational drug isatuximab is safe and effective when used in combination with standard agents for the treatment of newly diagnosed multiple myeloma.
This research is testing whether the investigational drug isatuximab is safe and effective when used in combination with standard agents for the treatment of newly diagnosed multiple myeloma.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
